chr17-12917329-G-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_014859.6(ARHGAP44):c.387+1318G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.224 in 153,760 control chromosomes in the GnomAD database, including 6,805 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.23   (  6790   hom.,  cov: 32) 
 Exomes 𝑓:  0.11   (  15   hom.  ) 
Consequence
 ARHGAP44
NM_014859.6 intron
NM_014859.6 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.379  
Publications
13 publications found 
Genes affected
 ARHGAP44  (HGNC:29096):  (Rho GTPase activating protein 44) Enables phospholipid binding activity. Predicted to be involved in several processes, including modification of dendritic spine; negative regulation of Rac protein signal transduction; and regulation of plasma membrane bounded cell projection organization. Located in leading edge membrane. [provided by Alliance of Genome Resources, Apr 2022] 
 MIR1269B  (HGNC:41787):  (microRNA 1269b) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.511  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.225  AC: 34243AN: 151984Hom.:  6769  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
34243
AN: 
151984
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0824  AC: 30AN: 364 AF XY:  0.0750   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
30
AN: 
364
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.107  AC: 178AN: 1658Hom.:  15  Cov.: 0 AF XY:  0.109  AC XY: 103AN XY: 948 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
178
AN: 
1658
Hom.: 
Cov.: 
0
 AF XY: 
AC XY: 
103
AN XY: 
948
show subpopulations 
African (AFR) 
 AF: 
AC: 
22
AN: 
60
American (AMR) 
 AF: 
AC: 
4
AN: 
14
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
6
East Asian (EAS) 
 AF: 
AC: 
9
AN: 
18
South Asian (SAS) 
 AF: 
AC: 
12
AN: 
44
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
4
Middle Eastern (MID) 
 AF: 
AC: 
71
AN: 
772
European-Non Finnish (NFE) 
 AF: 
AC: 
39
AN: 
610
Other (OTH) 
 AF: 
AC: 
21
AN: 
130
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.527 
Heterozygous variant carriers
 0 
 8 
 17 
 25 
 34 
 42 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 4 
 8 
 12 
 16 
 20 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.226  AC: 34305AN: 152102Hom.:  6790  Cov.: 32 AF XY:  0.227  AC XY: 16865AN XY: 74356 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
34305
AN: 
152102
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
16865
AN XY: 
74356
show subpopulations 
African (AFR) 
 AF: 
AC: 
21424
AN: 
41468
American (AMR) 
 AF: 
AC: 
2382
AN: 
15284
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
574
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
2218
AN: 
5146
South Asian (SAS) 
 AF: 
AC: 
1424
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
878
AN: 
10584
Middle Eastern (MID) 
 AF: 
AC: 
31
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
4983
AN: 
68020
Other (OTH) 
 AF: 
AC: 
387
AN: 
2106
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1065 
 2131 
 3196 
 4262 
 5327 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 318 
 636 
 954 
 1272 
 1590 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1226
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.